Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1207705

Liraglutide reduces hepatosteatosis in NAFLD and drug-induced fatty liver cell culture models through PPARγ signaling pathway


Omanovic Kolaric, Tea; Nincevic, Vjera; Kizivat, Tomislav; Zjalic, Milorad; Kuna, Lucija; Bili- Curcic, Ines; Smolic, Robert; Vcev, Aleksandar; Wu , George; Smolic, Martina
Liraglutide reduces hepatosteatosis in NAFLD and drug-induced fatty liver cell culture models through PPARγ signaling pathway // 3rd European Fatty Liver Conference
Maastricht, Nizozemska, 2022. str. 1-1 (predavanje, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 1207705 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Liraglutide reduces hepatosteatosis in NAFLD and drug-induced fatty liver cell culture models through PPARγ signaling pathway

Autori
Omanovic Kolaric, Tea ; Nincevic, Vjera ; Kizivat, Tomislav ; Zjalic, Milorad ; Kuna, Lucija ; Bili- Curcic, Ines ; Smolic, Robert ; Vcev, Aleksandar ; Wu , George ; Smolic, Martina

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Skup
3rd European Fatty Liver Conference

Mjesto i datum
Maastricht, Nizozemska, 2022

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Liraglutide ; non-alcoholic fatty liver disease ; amiodarone ; cell culture

Sažetak
Background: With the increasing prevalence of obesity, fatty liver injury, and drug use, appropriate treatment of non-alcoholic (NAFLD) and drug-induced fatty liver disease (DIFLD) is becoming more important. Numerous studies have proposed and tested a number of potential hepatoprotective agents. The aim of this study was to establish reliable cell culture models for NAFLD and DIFLD and to determine the effect of the GLP-1 agonist liraglutide in these models. Methods: Huh7 cells were grown overnight to reach 90% confluency, followed by 24h of incubation according to further described protocols. Experiments were performed in triplicates, with the following cell subgroups: Huh7 cells incubated in medium only as a negative control, cells incubated with increasing concentrations of liraglutide (5nM, 10nM, 20nM), cells treated with 0, 5 mM oleic acid (OA) (NAFLD model) , and/or cotreated with liraglutide, and cells treated with 20μM amiodarone (DIFLD model), and/or cotreated with liraglutide. The antiproliferative and cytotoxic effects were determined using a colorimetric MTT assay. Cells were stained with Oil-Red-O dye and Fluorescent mounting medium with DAPI, and visualized under a microscope. ImageJ software was used to count the cell nuclei and measure the integrated density relative to the cell count. After extraction of total RNA with NucleoZol, cDNA synthesis, PCR method and gel electrophoresis were performed, and finally the signals were analyzed by ImageJ software. Results: Both oleic acid and amiodarone reduced cell viability by 30% (p<0, 001, p<0, 05) compared to the control. Cells cotreated with lower concentrations of liraglutide (5 and 10nM) showed a slight increase in viability (p<0, 05), while higher concentration had an opposite effect. Both amiodarone and oleic acid significantly increased integrated density (p<0, 001), while 5nM liraglutide decreased it in cells cotreated with amiodarone (p<0, 05). PPARγ gene expression was decreased in both oleic acid and amiodarone treated cells, and 10nM liraglutide exerted greatest increase in PPARγ gene expression. Conclusions: Hepatoprotective effect of liraglutide in both models explored in this study is mediated through PPARγ signaling pathway.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Osijek,
Medicinski fakultet, Osijek,
Fakultet za dentalnu medicinu i zdravstvo, Osijek


Citiraj ovu publikaciju:

Omanovic Kolaric, Tea; Nincevic, Vjera; Kizivat, Tomislav; Zjalic, Milorad; Kuna, Lucija; Bili- Curcic, Ines; Smolic, Robert; Vcev, Aleksandar; Wu , George; Smolic, Martina
Liraglutide reduces hepatosteatosis in NAFLD and drug-induced fatty liver cell culture models through PPARγ signaling pathway // 3rd European Fatty Liver Conference
Maastricht, Nizozemska, 2022. str. 1-1 (predavanje, međunarodna recenzija, sažetak, znanstveni)
Omanovic Kolaric, T., Nincevic, V., Kizivat, T., Zjalic, M., Kuna, L., Bili- Curcic, I., Smolic, R., Vcev, A., Wu , G. & Smolic, M. (2022) Liraglutide reduces hepatosteatosis in NAFLD and drug-induced fatty liver cell culture models through PPARγ signaling pathway. U: 3rd European Fatty Liver Conference.
@article{article, author = {Omanovic Kolaric, Tea and Nincevic, Vjera and Kizivat, Tomislav and Zjalic, Milorad and Kuna, Lucija and Bili- Curcic, Ines and Smolic, Robert and Vcev, Aleksandar and Wu, George and Smolic, Martina}, year = {2022}, pages = {1-1}, keywords = {Liraglutide, non-alcoholic fatty liver disease, amiodarone, cell culture}, title = {Liraglutide reduces hepatosteatosis in NAFLD and drug-induced fatty liver cell culture models through PPARγ signaling pathway}, keyword = {Liraglutide, non-alcoholic fatty liver disease, amiodarone, cell culture}, publisherplace = {Maastricht, Nizozemska} }
@article{article, author = {Omanovic Kolaric, Tea and Nincevic, Vjera and Kizivat, Tomislav and Zjalic, Milorad and Kuna, Lucija and Bili- Curcic, Ines and Smolic, Robert and Vcev, Aleksandar and Wu, George and Smolic, Martina}, year = {2022}, pages = {1-1}, keywords = {Liraglutide, non-alcoholic fatty liver disease, amiodarone, cell culture}, title = {Liraglutide reduces hepatosteatosis in NAFLD and drug-induced fatty liver cell culture models through PPARγ signaling pathway}, keyword = {Liraglutide, non-alcoholic fatty liver disease, amiodarone, cell culture}, publisherplace = {Maastricht, Nizozemska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font